Semiconductors & Electronics Global On demand · 24-48h

Global Chip-based Targeted Analysis Sensor Market Strategic Research Report

Global Chip-based Targeted Analysis Sensor Market Strategic …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Chip-based Targeted Analysis Sensor Market
$8002025
8.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Biochip, Chemical Chip, Physical Chip

By Application: Medical Insurance, Environmental Monitoring, Food Safety, Industrial Manufacturing, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Bio-Rad Laboratories, Illumina, PerkinElmer, Agilent Technologies, Bruker Corporation, Bio-Techne Corporation, Fluidigm Corporation, NanoString Technologies, Luminex Corporation, QIAGEN, GE Healthcare, Sartorius AG, Randox Laboratories, Oxford Nanopore Technologies, Huajing Sensing Technology, Longwei Technology, Wuhan FineMEMS, Suzhou Integrated Micro System Technology, Shuangqiao Sensor Measurement and Control Technology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 152 pages
Market size 2025
$800
Million USD
Forecast CAGR
8.3%
2025-2032
Forecast 2032
$1397.9
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Chip-based Targeted Analysis Sensor market size is predicted to grow from US$ 800 million in 2025 to US$ 1,386 million in 2032; it is expected to grow at a CAGR of 8.3% from 2026 to 2032.

The chip-based targeted analytical sensor is an advanced sensor that integrates microchip technology and analytical sensor technology. It enables highly sensitive chemical or biological analysis in a tiny space and is often used to detect specific biomolecules or chemicals. Such sensors can bind to target molecules and generate signals through specific molecular recognition elements, such as antibodies, nucleic acids, or other ligands. Its highly integrated and miniaturized design makes it fast, sensitive and portable, and is widely used in biomedicine, environmental monitoring, food safety and other fields.

With the rapid development of IoT technology, the sensor chip market is constantly expanding. There is an increasing demand for accurate and high-performance sensor chips in the fields of modern automobiles, smartphones, computers, smart homes, industrial control, automotive electronics, medical electronics, financial security and smart security. The richness and diversity of these application scenarios make chip-based targeted analysis sensors one of the pillars of modern information technology. In summary, the market for chip-based targeted analysis sensors is continuing to grow and is expected to continue to maintain rapid growth.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Chip-based Targeted Analysis Sensor market?

What factors are driving Chip-based Targeted Analysis Sensor market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Chip-based Targeted Analysis Sensor market opportunities vary by end market size?

How does Chip-based Targeted Analysis Sensor break out by Type, by Application?

This report presents a comprehensive overview of the global Chip-based Targeted Analysis Sensor market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Biochip
  • Chemical Chip
  • Physical Chip

Segment by Application

  • Medical Insurance
  • Environmental Monitoring
  • Food Safety
  • Industrial Manufacturing
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Chip-based Targeted Analysis Sensor market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Medical Insurance, Environmental Monitoring, Food Safety evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Chip-based Targeted Analysis Sensor Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$800
2025
Forecast
$1397.9
2032
CAGR
8.3%
2025–2032
Regiones
5
global
Key companies
Roche DiagnosticsAbbott LaboratoriesThermo Fisher ScientificSiemens HealthineersBio-Rad LaboratoriesIlluminaPerkinElmerAgilent Technologies
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
BiochipChemical ChipPhysical Chip
By Application
Medical InsuranceEnvironmental MonitoringFood SafetyIndustrial ManufacturingOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Biochip
  • 3.1.3 Chemical Chip
  • 3.1.4 Physical Chip
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Medical Insurance
  • 4.1.3 Environmental Monitoring
  • 4.1.4 Food Safety
  • 4.1.5 Industrial Manufacturing
  • 4.1.6 Other
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Roche Diagnostics
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Abbott Laboratories
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Thermo Fisher Scientific
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Siemens Healthineers
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Bio-Rad Laboratories
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Illumina
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 PerkinElmer
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Agilent Technologies
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Bruker Corporation
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Bio-Techne Corporation
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Fluidigm Corporation
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 NanoString Technologies
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Luminex Corporation
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 QIAGEN
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 GE Healthcare
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Sartorius AG
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Randox Laboratories
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Oxford Nanopore Technologies
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Huajing Sensing Technology
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Longwei Technology
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Wuhan FineMEMS
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Suzhou Integrated Micro System Technology
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Shuangqiao Sensor Measurement and Control Technology
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Chip-based Targeted Analysis Sensor market size?
The global Chip-based Targeted Analysis Sensor market is estimated at US$ 800 million in 2025 (base year) and is projected to reach US$ 1.39 billion by 2032.
What growth rate is expected for the Chip-based Targeted Analysis Sensor market through 2032?
The market is expected to grow at a CAGR of 8.3% from 2026 to 2032, expanding from US$ 800 million in 2025 to US$ 1.39 billion in 2032, roughly 1.7 times its base-year value.
How is Chip-based Targeted Analysis Sensor defined?
The chip-based targeted analytical sensor is an advanced sensor that integrates microchip technology and analytical sensor technology. It enables highly sensitive chemical or biological analysis in a tiny space and is often used to detect specific biomolecules or chemicals. Such sensors can bind to target molecules and generate signals through specific molecular recognition elements, such as antibodies, nucleic acids, or other ligands.
What are the main segments of the Chip-based Targeted Analysis Sensor market by type?
By type, the market is segmented into Biochip, Chemical Chip and Physical Chip.
Which applications drive demand in the Chip-based Targeted Analysis Sensor market?
Key applications covered include Medical Insurance, Environmental Monitoring, Food Safety, Industrial Manufacturing and Other.
Who are the key players in the Chip-based Targeted Analysis Sensor market?
Key players profiled include Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Bio-Rad Laboratories, Illumina, PerkinElmer and Agilent Technologies, among 23 companies covered in total.
Which regions and countries are covered for Chip-based Targeted Analysis Sensor?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Chip-based Targeted Analysis Sensor market?
What factors are driving Chip-based Targeted Analysis Sensor market growth, globally and by region?
Who should buy the Chip-based Targeted Analysis Sensor market report?
The report is intended for manufacturers and solution providers, distributors and end users in Medical Insurance, Environmental Monitoring and Food Safety, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Chip-based Targeted Analysis Sensor market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.